-
Mashup Score: 3Underneath the White Coat: Hypogonadism Among Male Resident Physicians - American Urological Association - 2 day(s) ago
Hypogonadism is a significant medical condition that has been gaining increased attention in recent years. The prevalence of hypogonadism varies, with estimates ranging from 2.1% to 30% in men ages 40 to 79, depending on the definition and population studied. The economic burden of hypogonadism is substantial, with one study estimating the 20-year cost of testosterone deficiency in US men ages 45 to 74 at $190 billion to $525 billion. The importance of addressing hypogonadism is underscored by its potential long-term health impacts, including increased risk of cardiovascular disease and osteoporosis.
Source: auanews.netCategories: General Medicine News, UrologyTweet
-
Mashup Score: 6
Bladder cancer continues to represent a significant challenge in the US, with an estimated 83,190 new cases in 2024 and growing costs of care. For decades the backbone of bladder cancer treatment has revolved around bacillus Calmette-Guérin (BCG) followed by radical cystectomy for those found to have unresponsive disease. We now find ourselves at the precipice of an exciting era where we can offer several choices to delay or ultimately eliminate the need for radical cystectomy in a cohort of patients. Development of an effective, safe, and durable treatment remains a critically unmet need for this population. Due to the abundance of recent trials and approvals, we will focus on advancements in the nonmuscle-invasive disease space.
Source: auanews.netCategories: General Medicine News, UrologyTweet-
This #AUANews article talks about emerging treatments in bladder cancer and how it continues to represent a significant challenge in the US, with an estimated 83,190 new cases in 2024 and growing costs of care. Read here ➡️ https://t.co/GvQ7kCSqPG #BladderHealthMonth #Urology https://t.co/hQgBfwpRGe
-
-
Mashup Score: 3
The First FDA-Approved Intravesical Non-Replicating Gene Therapy for High-Risk Non–Muscle-Invasive Bladder Cancer
Source: auanews.netCategories: General Medicine News, UrologyTweet-
Join us! Dr. Aditya Bagrodia will discuss the role of a novel treatment in patients with high-risk BCG-unresponsive NMIBC. Learn more here ➡️ https://t.co/pRuk0pd588 #AUANewsworthy #Urology #AUA https://t.co/WRCwQbEHJo
-
-
Mashup Score: 4AUA AWARD WINNERS Rethinking Routine Ureteral Stenting After Ureteral Access Sheath Use for Ureteroscopy - American Urological Association - 10 day(s) ago
Ureteroscopy is the most common procedure for patients with urinary stones in the United States. Developments in endoscopic technology, lasers, and instrumentation have increased its availability and driven many advances in techniques over the last decade. One commonly used device is the ureteral access sheath (UAS).
Source: auanews.netCategories: General Medicine News, UrologyTweet-
#AUANews 📰 AUA AWARD WINNERS Rethinking Routine Ureteral Stenting After Ureteral Access Sheath Use for Ureteroscopy Read the full article here ➡️ https://t.co/ffOcNwGUl5 #Urology #AUA https://t.co/sZC0ayXFnS
-
-
Mashup Score: 3
The current gold standard for patients with terminal bladder pathology involves urinary reconstruction using a vascularized segment of intestine, which carries an inherent predisposition to a variety of early and late metabolic, infectious, nutritional, and renal complications. These are common and carry significant morbidity and mortality. The incidence of 1 or more of these complications ranges from 40% to 80%, and readmission rates range from 25% to 30% within 3 months after surgery. Replacement of the diseased bladder with a more normal urinary reservoir could circumvent these complications. Recently, the necessary preclinical work, including robotic bladder autotransplantation in brain-dead but heart-beating human research donors was described.
Source: auanews.netCategories: General Medicine News, UrologyTweet-
Check out this award-winning study, which discusses whether immune tolerance protocols employing mixed chimerism be utilized in vascularized composite allografts (VCAs) obtained from deceased donors, including VCBAs. Read here ➡️ https://t.co/xm4rdZBBut #BladderHealthMonth https://t.co/YqRWusMZYx
-
-
Mashup Score: 3
The First FDA-Approved Intravesical Non-Replicating Gene Therapy for High-Risk Non–Muscle-Invasive Bladder Cancer
Source: auanews.netCategories: General Medicine News, UrologyTweet-
Join us! Dr. Aditya Bagrodia will discuss the role of a novel treatment in patients with high-risk BCG-unresponsive NMIBC. Learn more here ➡️ https://t.co/pRuk0pd588 #AUANewsworthy #Urology #AUA https://t.co/WRCwQbEHJo
-
-
Mashup Score: 3What Qualitative Analysis Tells Us About the Experience of Men Undergoing Urethroplasty - American Urological Association - 23 day(s) ago
Urethral stricture disease is a relatively common occurrence, affecting approximately 1% of the US male population. Despite the known overall poor long-term efficacy, endoscopic management remains the mainstay of care for men with strictures both as primary treatment, as well as for recurrent disease.
Source: auanews.netCategories: General Medicine News, UrologyTweet-
Hear from the author! @nielsvjohnsen, author of the #AUANews article "What Qualitative Analysis Tells Us About the Experience of Men Undergoing Urethroplasty," gives some insights into his study on urethral stricture disease. Read here ➡️ https://t.co/yhBOpwZ2uX #AUA #Urology https://t.co/6ujHRDfJOh
-
-
Mashup Score: 2My Experience as a 2024 AUA/JUA Exchange Program Scholar: An Unforgettable Academic and Cultural Immersion - American Urological Association - 1 month(s) ago
I had the honor and privilege to participate as an exchange scholar in the 2024 AUA Exchange Program with the Japanese Urological Association (JUA). During my exchange, which took place in April 2024, I spent considerable time with the faculty and residents in the Department of Urology at Dokkyo Medical University in Japan, led by Professor Takao Kamai (Figures 1 and 2). The experience culminated with the 111th Annual Meeting of the JUA in Yokohama on April 25 to 27, 2024
Source: auanews.netCategories: General Medicine News, UrologyTweet-
#AUANews 📰 "My Experience as a 2024 AUA/JUA Exchange Program Scholar: An Unforgettable Academic and Cultural Immersion" Read here ➡️ https://t.co/Q4gXmeOkK7 #AUA #Urology https://t.co/BB0vgawKfe
-
-
Mashup Score: 0Lithotripsy for Small, Nonobstructing Renal Calculi - American Urological Association - 1 month(s) ago
Small renal calculi are often asymptomatic and incidentally detected on imaging modalities during the workup of other medical conditions. While the treatment approach is clearer for symptomatic and larger renal calculi, managing smaller and lower-burden stones depends on patient history, imaging, and laboratory studies. Although most nonobstructing small renal stones are asymptomatic, they may still progress to become symptomatic either due to infection or obstruction in up to one-third of cases.
Source: auanews.netCategories: General Medicine News, UrologyTweet-
#AUANews 📰 "Lithotripsy for Small, Nonobstructing Renal Calculi" Read here ➡️ https://t.co/OSD3FKCbeB #AUA #Urology https://t.co/DjDyRpkO2E
-
-
Mashup Score: 0Illucix and PSMA Imaging for the Initial Staging of Prostate Cancer - American Urological Association - 1 month(s) ago
Illucix and PSMA Imaging for the Initial Staging of Prostate Cancer
Source: auanews.netCategories: General Medicine News, UrologyTweet-
Happening October 17th, 2024 💻 👉 Dr. Kella will cover case studies illustrating the clinical utility of Illuccix and provide an understanding of the mode of action for Illuccix and the radiographic PET/CT findings in prostate cancer. Register here ➡️ https://t.co/J56mTNbRiI https://t.co/QgwrW56DDP
-
#AUANews 📰 "Underneath the White Coat: Hypogonadism Among Male Resident Physicians" Read here ➡️ https://t.co/ZeybUcujYM #AUA #Urology https://t.co/bkODIbiZQe